Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

U.S. Gold Corp. (USAU)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
4.3600+0.5600 (+14.74%)
At close: 04:00PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Short-term KST

Short-term KST

Previous Close3.8000
Open3.8200
Bid4.3600 x 1000
Ask5.4900 x 1000
Day's Range3.8200 - 4.4300
52 Week Range3.7100 - 11.6300
Volume130,970
Avg. Volume52,079
Market Cap36.405M
Beta (5Y Monthly)1.69
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateMay 07, 2018
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for USAU

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • U.S. Gold Corp.
    Analyst Report: Exact Sciences CorporationExact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact’s Cologuard screening test, a non-invasive stool-based DNA test, is a pre-cancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a genetic-based treatment selection test for breast, prostate, and colon cancers. With the acquisitions of Base Genomics and Thrive Earlier Detection, Exact is building a multi-cancer early screening test to detect over 14 cancers, a test that would be one of earliest entrants in multi-cancer liquid biopsy cancer screening.
    Rating
    Fair Value
    Economic Moat
    yesterdayMorningstar
View more
  • Reuters

    Gold slips as dollar, yields strengthen on robust U.S. jobs data

    Gold prices fell on Monday as the dollar and Treasury yields firmed after a solid U.S. payrolls report raised expectations of aggressive rate hikes, although the Ukraine crisis and talks of more sanctions against Russia supported safe-haven demand. Spot gold was down 0.3% at $1,917.55 per ounce by 0434 GMT. "While the conflict in Eastern Europe may be providing a modest tailwind to gold prices on dips, it is very clear now that the main pricing inputs into gold have swung to the impact of higher U.S. yields and a higher U.S. dollar," said OANDA senior analyst Jeffrey Halley.

  • Simply Wall St.

    U.S. Gold (NASDAQ:USAU) Will Have To Spend Its Cash Wisely

    Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...

  • Zacks

    U.S. Gold Corp. (USAU) Sees Hammer Chart Pattern: Time to Buy?

    U.S. Gold Corp. (USAU) recently saw a Hammer Chart Pattern which can signal that the stock is nearing a bottom.

Advertisement
Advertisement